Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ?

Breast Cancer Research and Treatment

Volumn 87, Issue 3, 2004, Pages 265-272

  Rakovitch, Eileen ^a   Mihai, Alina ^a   Pignol, Jean Philippe ^a   Hanna, Wedad ^a   Kwinter, Jennifer ^a   Chartier, Carole ^a   Ackerman, Ida ^a   Kim, John ^a   Pritchard, Kathleen ^b   Paszat, Lawrence ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Breast cancer; Ductal carcinoma; Interobserver variability; Pathology

Indexed keywords

ADULT; AGED; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBSERVER VARIATION; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SCREENING; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MEDICAL RECORDS; MIDDLE AGED; OBSERVER VARIATION; ONTARIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 8644290924     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-9454-8     Document Type: Review

References (26)

1. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275: 913-918, 1996
2. Ernster VL, Barclay J: Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. [Review] [34 refs]. J Natl Cancer List Monogr: 151-156, 1997
3. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, Kavanah M: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16: 441-452, 1998
4. Fourquet A, Zafrani B, Campana F, Clough KB: Institute Curie experience. In: Silverstein MJ (ed) Ductal Carcinoma In situ. Williams & Wilkins, Baltimore, 1997, pp 385-390
5. Silverstein MJ: Van Nuys Experience by Treatment. In: Silverstein MJ (ed) Ductal Carcinoma In Situ. Williams & Wilkins, Baltimore, 1997, pp 443-447
6. Solin LJ, Kurtz J, Fourquet A, Amalric R, Recht A, Bornstein BA, Kuske R, Taylor M, Barren W, Fowble B, Haffty B, Schultz DJ, Yeh IT, McCormick B, McNeese M: Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14: 754-763, 1996
7. Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, Di Palma S, Simony-Lafontaine J, de Mascard I, van de Vijver, MJ: Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19: 2263-2271, 2001
8. Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Olmark N: Pathologic Findings from the National Surgical Adjuvant Breast Project (NSABP) Eight-Year Update of Protocol B-17. Cancer 86: 429-438, 1999
9. Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, van Dongen JA: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355: 528-533, 2000
10. Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ: The influence of margin width on local control of ductal carcinoma in situ of the breast. New England J Med 340: 1455-1461, 1999
11. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI: Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. [Review] [3 refs]. Cancer 2000. Feb. 15, 946-954, 1988
12. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: The management of ductal carcinoma in situ (DCIS). Can Med Assoc J 158(3 Suppl): S27-S34, 1998
13. Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M: UK Coordinating Committee on Cancer Research, Ductal Carcinoma in situ Working Party, and DCIS trialists in the UK, A. a. N. Z. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 12(362): 95-102, 2003
14. Olivotto I, Levine M: Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). [Review] [8 refs]. CMAJ Can Med Association J 165: 912-913, 2001
15. Recht A, Rutgers EJ, Fentiman IS, Kurtz JM, Mansel RE, Sloane JP: The fourth EORTC DCIS Consensus meeting (Chateau Marquette, Heemskerk, The Netherlands, 23-24 January 1998) - conference report. [Review] [42 refs]. European J Cancer 34: 1664-1669, 1998
16. Silverstein MJ: Predicting local recurrences in patients with ductal carcinoma in situ. In: Silverstein MJ (ed), Ductal Carcinoma In Situ. Williams and Wilkins, Balimore, 1997, pp 271-283
17. Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Dervan P, Eusebi V, De Miguel C, Drijkoningen M, Elston CW, Faverley D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B: Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol 29: 1056-1062, 1998
18. Douglas-Jones AG, Morgan JM, Appleton MA, Attanoos R, Caslin A, Champ CS, Cotter M, Dallimore NS, Dawson A, Fortt RW, Griffiths AP, Hughes M, Kitching PA, O'Brien C, Rashid AM, Stock D, Verghese A, Williams DW, Williams NW, Williams S: Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast. J Clin Pathol 53: 596-602, 2000
19. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer 75: 1310-1319, 1995
20. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN: A prognostic index for ductal carcinoma in situ of the breast. Cancer 77: 2267-2274, 1996
21. Elwood M: Critical Appraisal of Epidemiological Studies and Clinical Trials. Oxford, 1998
22. Standards for the management of ductal carcinoma in situ of the breast (DCIS). 2004. Ref Type: Internet Communication
23. Staradub VL, Messenger KA, Hao N, Wiley EL, Morrow M: Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol 9: 982-987, 2002
24. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham DL, Deutsch M, Ore L: Lumpectomy compared with himpectomy and radiation therapy for the treatment of intraductal breast cancer. New England J Med 328: 1581-1586, 1993
25. Lagios MD, Margolin FR, Westdahl PR, Rose MR: Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63; 618-624, 1989
26. Schwartz GF: The role of excision and surveillance alone in subclinical DCIS of the breast. Oncology (Huntingt) 8: 21-26 discussion, 1994